Status:
UNKNOWN
Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer
Lead Sponsor:
The First Affiliated Hospital of Dalian Medical University
Conditions:
Liver Cancer
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
The clinical trail of Cinobufacini combined with TACE on primary liver cancer.The trail is randomized controled.Patients are diagnosed primary liver cancer based on pathology or cell biology.They are ...
Detailed Description
The clinical trail of Cinobufacini combined with TACE on primary liver cancer.The trail is randomized controled.Patients are diagnosed primary liver cancer based on pathology or cell biology.They are ...
Eligibility Criteria
Inclusion
- Age:18-70 years.
- male and female.
- signed the informed consent form.
- Diagnosis:Primary liver cancer diagnosed by imaging、cell and pathology report.
- Eastern Cooperative Oncology Group (ECOG) :0-2;life expectancy more than 3 months.
- Indication for TACE,no contraindication.
- First time chemotherapy or at least 6 months after last chemotherapy and radiotherapy.
- At least 8 weeks after last biotherapy.
- Surgery：had not received transplantation surgery,at least 2 weeks after last major surgery.
Exclusion
- Chemotherapy is contraindicated.
- Have the primary disease can cause the neuropathy.
- A history of other malignant tumor in recent 5 years.
- Less than 6 months after last chemotherapy or radiotherapy.
- Less than 8 months after last.
- Cinobufacini allergy.
- Had received transplantation surgery ,less than 2 weeks after last major surgery.
- Other researchers think is not suitable for this clinical trail.
Key Trial Info
Start Date :
January 27 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03843229
Start Date
January 27 2019
End Date
September 1 2020
Last Update
February 18 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Dalian Medical University
Dalian, Liaoning, China, 116000